These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 20479715)

  • 1. Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner.
    Roxas JL; Koutsouris A; Bellmeyer A; Tesfay S; Royan S; Falzari K; Harris A; Cheng H; Rhee KJ; Hecht G
    Lab Invest; 2010 Aug; 90(8):1152-68. PubMed ID: 20479715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
    Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
    Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice.
    Han X; Fink MP; Yang R; Delude RL
    Shock; 2004 Mar; 21(3):261-70. PubMed ID: 14770040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
    Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
    Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.
    Bellmeyer A; Cotton C; Kanteti R; Koutsouris A; Viswanathan VK; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G576-81. PubMed ID: 19556613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redistribution of tight junction proteins during EPEC infection in vivo.
    Zhang Q; Li Q; Wang C; Li N; Li J
    Inflammation; 2012 Feb; 35(1):23-32. PubMed ID: 21170673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.
    Mennigen R; Nolte K; Rijcken E; Utech M; Loeffler B; Senninger N; Bruewer M
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1140-9. PubMed ID: 19221015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium.
    In J; Lukyanenko V; Foulke-Abel J; Hubbard AL; Delannoy M; Hansen AM; Kaper JB; Boisen N; Nataro JP; Zhu C; Boedeker EC; Girón JA; Kovbasnjuk O
    PLoS One; 2013; 8(7):e69196. PubMed ID: 23874912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability.
    Howe KL; Reardon C; Wang A; Nazli A; McKay DM
    Am J Pathol; 2005 Dec; 167(6):1587-97. PubMed ID: 16314472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells.
    Lukyanenko V; Malyukova I; Hubbard A; Delannoy M; Boedeker E; Zhu C; Cebotaru L; Kovbasnjuk O
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1140-9. PubMed ID: 21832249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin remodels the intestinal epithelial transcriptional response to Enterohemorrhagic Escherichia coli.
    Warr AR; Kuehl CJ; Waldor MK
    PLoS Pathog; 2021 Feb; 17(2):e1009290. PubMed ID: 33529199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel murine infection model for Shiga toxin-producing Escherichia coli.
    Mallick EM; McBee ME; Vanguri VK; Melton-Celsa AR; Schlieper K; Karalius BJ; O'Brien AD; Butterton JR; Leong JM; Schauer DB
    J Clin Invest; 2012 Nov; 122(11):4012-24. PubMed ID: 23041631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models.
    Golan L; Gonen E; Yagel S; Rosenshine I; Shpigel NY
    Dis Model Mech; 2011 Jan; 4(1):86-94. PubMed ID: 20959635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo.
    Miyamoto Y; Iimura M; Kaper JB; Torres AG; Kagnoff MF
    Cell Microbiol; 2006 May; 8(5):869-79. PubMed ID: 16611235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection.
    Yi H; Hu W; Chen S; Lu Z; Wang Y
    J Immunol; 2017 Feb; 198(4):1696-1705. PubMed ID: 28062699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.
    Johnson-Henry KC; Donato KA; Shen-Tu G; Gordanpour M; Sherman PM
    Infect Immun; 2008 Apr; 76(4):1340-8. PubMed ID: 18227169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteropathogenic Escherichia coli changes distribution of occludin and ZO-1 in tight junction membrane microdomains in vivo.
    Zhang Q; Li Q; Wang C; Liu X; Li N; Li J
    Microb Pathog; 2010 Jan; 48(1):28-34. PubMed ID: 19833191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-inflammatory capacity of Escherichia coli O104:H4 outbreak strain during colonization of intestinal epithelial cells from human and cattle.
    Stalb S; Barth SA; Sobotta K; Liebler-Tenorio E; Geue L; Menge C
    Int J Med Microbiol; 2018 Oct; 308(7):899-911. PubMed ID: 29937390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
    Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
    J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.